Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetes
{{output}}
This study investigated the safety and feasibility of daily ingestion of autologous lyophilized fecal microbiota capsules (a-LFMCs) for preserving beta-cell function in individuals with type 1 diabetes (T1D). We evaluated a-LFMC in an open-label, single-arm pi... ...
